Featuring a slide presentation and related discussion from Dr Daniel Lenihan.

CME information and select publications

Featuring perspectives from Drs Richard Furman, Lindsey Roeker and Daniel Lenihan, including the following topics:

• Introduction (0:00)
• Chronic Lymphocytic Leukemia (CLL) (1:37)
• Case: A woman in her early 70s with recurrent CLL and ibrutinib-associated atrial fibrillation — Warren S Brenner, MD (3:30)
• Case: A woman in her mid-40s with CLL in remission on ibrutinib who experiences ventricular fibrillation — Daniel J Lenihan, MD (29:16)
• Case: A man in his late 70s with CLL who receives obinutuzumab/venetoclax — Dr Brenner (38:22)
• Mantle Cell Lymphoma (MCL) (53:25)
• Novel Agents and Strategies in CLL and MCL (54:46)

CME information and select publications

Featuring perspectives from Drs Jamie Chaft, Solange Peters, Brendan Stiles and Eric Vallieres, including the following topics:

• Effect of the recent practice-changing data sets in the adjuvant and neoadjuvant treatment of non-small cell lung carcinoma (NSCLC) (0:00)
• Case: A woman in her late 60s with Stage IIIA squamous cell carcinoma of the lung and a high level of PD-L1 expression (7:46)
• Strategies to aid shared decision-making in the adjuvant setting for NSCLC (23:43)
• Potential role of circulating tumor DNA to detect minimal residual disease in the adjuvant and neoadjuvant settings (28:06)
• Choosing definitive stereotactic radiosurgery versus sublobar resection in patients with NSCLC (34:53)
• Case: A woman in her early 80s with PD-L1-negative, Stage IIB lung adenocarcinoma with PIK3CA and TP53 mutations and HER2 amplification (37:24)
• Experiences with surgery after neoadjuvant systemic therapy in NSCLC (55:38)
• Case: A woman in her mid-70s with localized pulmonary adenocarcinoma with a MET exon 14 skipping mutation (1:06:23)
• Clinical outcomes from the Phase III CheckMate 816 trial assessing nivolumab in combination with chemotherapy as neoadjuvant therapy for Stage IB-IIIA NSCLC (1:21:36)
• Case: A 48-year-old man with a 3.1-cm, Stage IB NSCLC with an EGFR exon 19 deletion (1:35:20)
• Management of oligometastatic disease with surgery and radiation therapy (1:43:32)
• Numeracy in adjuvant therapy for NSCLC; estimating the benefit to aid patients in therapeutic decision-making (1:49:11)

CME information and select publications

Featuring an interview with Dr Ruben Mesa, including the following topics:

• Management of myeloproliferative neoplasms (MPNs) (0:00)
• Case: A man in his early 40s with MPN with a JAK2 mutation (27:17)
• Case: A man in his mid-50s with disease exacerbation 14 years after diagnosis of polycythemia vera (PV) (28:24)
• Case: A man in his mid-70s with post-PV myelofibrosis and resistance to ruxolitinib (30:50)

CME information and select publications

Featuring perspectives from Dr Sara Tolaney, including the following topics:

• Introduction: DESTINY-Breast03 (0:00)
• Case: A woman in her early 50s with ER/PR-negative, HER2-positive breast cancer with bone, lung, liver and brain metastases — Justin Peter Favaro, MD, PhD (14:02)
• Case: A woman in her mid-70s with ER-positive, PR-negative, HER2-positive metastatic breast cancer — Sulfi Ibrahim, MD (18:38)
• Case: A woman in her early 60s with a localized 3.5-cm weakly ER/PR-positive, HER2-positive, node-negative breast cancer — Andrea Stebel, MD (28:18)
• Case: A woman in her early 40s with localized ER-negative, HER2-positive breast cancer — Ann Partridge, MD, MPH (31:04)
• Case: A woman in her early 40s with localized ER-positive, HER2-positive breast cancer — Kelly Yap, MD (36:26)
• Case: A woman in her late 30s with ER/PR-positive, HER2-positive, node-positive inflammatory breast cancer — Benjamin Parsons, DO (46:29)

CME information and select publications

Featuring perspectives from Dr Loretta Nastoupil, including the following topics:

• Introduction (0:00)
• Case: A man in his late 60s with recurrent diffuse large B-cell lymphoma and disease progression after autologous stem cell transplant (8:29)
• Case: A man in his early 30s with classic nodular sclerosing Hodgkin lymphoma (22:46)
• Case: A man in his early 70s with follicular lymphoma who experiences disease relapse 1 year after completing lenalidomide/rituximab (27:25)
• Case: A man in his late 50s with relapsed mantle cell lymphoma after chimeric antigen receptor T-cell therapy (44:44)

CME information and select publications

Featuring perspectives from Dr Jonathan Rosenberg, including the following topics:

• Introduction: Antibody-drug conjugates in the news (0:00)
• Case: A man in his early 70s with metastatic urothelial bladder cancer (mUBC) — Helen H Moon, MD (9:19)
• Case: A woman in her mid 80s with non-muscle-invasive UBC with an FGFR2 tumor mutation — Henna Malik, MD (15:14)
• Case: A woman in her early 70s with mUBC, PD-L1 30% — Sulfi Ibrahim, MD (27:46)
• Case: A woman in her mid-70s with BCG-refractory non-muscle-invasive bladder carcinoma in situ — Jason Hafron, MD (48:23)
• Case: A man in his early 60s with BCG-refractory non-muscle-invasive UBC — Dr Ibrahim (52:49)

CME information and select publications

Featuring an interview with Dr Michael Mauro, including the following topics:

• Management of chronic myeloid leukemia (CML) (0:00)
• Case: A woman in her early 40s who received imatinib for 20 years for chronic-phase (CP) CML (37:45)
• Case: A man in his mid-60s with CP CML and cardiovascular risk factors (39:01)
• Case: A man in his early 50s with intermediate-risk CP CML 5 years undetectable on asciminib (40:43)

CME information and select publications

Featuring perspectives from Drs Andrew Evens, Ian Flinn and Gilles Salles, including the following topics:

• Introduction (0:00)
• Follicular Lymphoma (FL) (1:40)
• Case: A man in his early 70s with relapsed/refractory (R/R) FL — Andrew M Evens, DO, MSc (6:47)
• Case: A woman in her late 60s with R/R FL and an EZH2 mutation — Ian W Flinn, MD, PhD (15:00)
• Mantle Cell Lymphoma (MCL) (21:40)
• Case: A man in his early 70s with MCL — Dr Flinn (28:51)
• Case: A woman in her late 60s with MCL who received a Bruton tyrosine kinase inhibitor and received chimeric antigen receptor (CAR) T-cell therapy — Dr Evens (33:18)
• Case: A man in his early 60s with R/R MCL — Dr Flinn (36:04)
• Diffuse Large B-Cell Lymphoma (DLBCL) (37:41)
• Case: A man in his early 80s with R/R DLBCL — Dr Flinn (43:53)
• Case: A woman in her late 70s with DLBCL — Gilles Salles, MD, PhD (46:46)
• Case: A man in his late 20s with R/R DLBCL treated with CAR T-cell therapy — Dr Salles (51:00)

CME information and select publications

Featuring perspectives from Dr John Leonard and Ms Amy Goodrich, including the following topics:

• Introduction (0:00)
• Diffuse Large B-Cell Lymphoma (1:24)
• Case: A man in his late 20s with newly diagnosed Hodgkin lymphoma — Amy Goodrich, CRNP (23:50)
• Hodgkin Lymphoma (27:04)
• Follicular Lymphoma (37:25)
• Case: A woman in her early 50s with Stage IVB follicular lymphoma — Ms Goodrich (45:25)
• Mantle Cell Lymphoma (50:52)
• Case: A man in his late 50s with Stage IVB mantle cell lymphoma — Ms Goodrich (53:53)

NCPD information and select publications